Blogs
A Look at AstraZeneca Price Targets -- Seeking Alpha
<strong><a href='http://pulse.alacra.com/blog/'>Alacra Pulse Check Blog</a>submits:</strong><p><em><span>By<span>Karen Schwartz</span></span></em><span></p><div><div><div><div><p><img src="http://static.seekingalpha.com/uploads/2010/10/17/saupload_azn_logo1.png" align="right" hspace="6" vspace="6"
Big Pharma become Team Pharma
Home | Contact Us | Advertise | About Us | Privacy Policy | News Archive Medicine Politics Practice Ideas Other stuff Jobs Search [BLOG HOMEPAGE] Big Pharma become Team Pharma By Michael Woodhead,
Januvia Linked to Pancreatitis by FDA - Health Blog - WSJ
An FDA notice on Merck's Januvia comes just over a year after Byetta was also linked to pancreatitis.
Blog. The Global Challenge of Infectious Disease
Posted by Ben Hewett on November 13, 2008 at 12:43 pm[pg] [pg] The talk of the town since the conclusion of this historic election has been understandably focused on on how to fix the economy, pull ou
Merck / J&J Rheumatoid Arthritis Drug Arbitration Delayed: What's at Stake? -- Seeking Alpha
<strong><a href='http://www.pharmalot.com/'>Pharmalot</a>submits:</strong><p>The closely watched dispute between Merck (<a href='http://seekingalpha.com/symbol/mrk' title='Merck& Co. Inc.'>MRK</a>) and Johnson& Johnson (<a href='http://seekingalpha.com/symbol/jnj' title='Johnson&
Pfizer Picks Ups King in Expansion of Pain Franchise -- Seeking Alpha
<strong><a href='http://www.burrillreport.com/'>The Burrill Report</a>submits:</strong><p><em>By Michael Fitzhugh</em></p><p>Pfizer (<a href='http://seekingalpha.com/symbol/pfe' title='Pfizer Inc.'>PFE</a>), the world’s largest pharmaceutical company, is moving to bolster its pain medications
A Third Mega-Deal Done, Pfizer Still Needs New Drugs -- Seeking Alpha
<strong><a href='http://www.trefis.com/splash?to=/'>Trefis</a>submits:</strong><div><p>Pfizer (<a href='http://seekingalpha.com/symbol/pfe' title='Pfizer Inc.'>PFE</a>) paid $90 billion for Warner Lambert a decade ago, then added Pharmacia, at a cost of $60 billion, about three years later, and
Pfizer Beefs Up Pain Portfolio With King Pharma Buy -- Seeking Alpha
<strong><a href='http://www.pharmalot.com/'>Pharmalot</a>submits:</strong><p>In the latest example of how Pfizer (<a href='http://seekingalpha.com/symbol/pfe' title='Pfizer Inc.'>PFE</a>) is trying to become a Hollywood-like conglomerate, the drugmaker has agreed to pay $3.6 billion to buy King
Pfizer Is Not Paying a Ransom for King -- Seeking Alpha
<strong><a href='http://www.epvantage.com/'>EP Vantage</a>submits:</strong><p>Considering<a>King Pharmaceuticals</a>' (<a href='http://seekingalpha.com/symbol/kg' title='King Pharmaceuticals Inc.'>KG</a>) share price has not been anywhere close to $14.25 in the last three
Novartis Moves to Speed Up Flu Vaccine Production -- Seeking Alpha
<strong><a href='http://www.burrillreport.com/'>The Burrill Report</a>submits:</strong><p><em>By Michael Fitzhugh</em></p><p>Novartis (<a href='http://seekingalpha.com/symbol/nvs' title='Novartis AG'>NVS</a>) is hoping to shave two months off the usual time required to produce its annual flu
Refine by Content Type:
Refine by Source:
- seekingalpha.com (380)
- www.genengnews.com (6)
- blogs.wsj.com (1)
- www.6minutes.com.au (1)
